Efficacy and Safety Analysis of Transarterial Chemoembolization Combined with Sintilimab Plus Bevacizumab Biosimilar in the Treatment of Unresectable Hepatocellular Carcinoma

Huixia Qin,1,* Kaiwen Jiang,2,* Chengyuan Liu,2,* Hesheng Lin,2,* Jing Xia,2,* Houxiang Ya,2 Jing Gu,2 Liya Suo,2 Bo Li,2 Xin Deng,2 Dejie Wang,3 Xiaowang Huang,3 Shuqun Li2 1Interventional Center, The First Affiliated Hospital of Guilin Medical University, Gu...

Полное описание

Библиографические подробности

Главные авторы:	Qin H, Jiang K, Liu C, Lin H, Xia J, Ya H, Gu J, Suo L, Li B, Deng X, Wang D, Huang X, Li S
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Dove Medical Press 2025-08-01
Серии:	Journal of Hepatocellular Carcinoma
Предметы:	Unresectable hepatocellular carcinoma Sintilimab Bevacizumab biosimilar Transarterial chemoembolization
Online-ссылка:	https://www.dovepress.com/efficacy-and-safety-analysis-of-transarterial-chemoembolization-combin-peer-reviewed-fulltext-article-JHC
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!